Taber's Medical Dictionary
factor
(fak′tŏr)
[L. factor, maker]
1. A contributing cause in an action.
2. In genetics, a gene.
3. An essential chemical such as a vitamin or immunoglobulin.
angiogenic growth factor
Any of a group of polypeptides that stimulate the formation of new blood vessels. They include agents like vascular endothelial growth factor (VEGF) and blood vessel fibroblastic growth factor (bFGF). These factors are active in healing wounds, chronic inflammatory conditions, retrolental fibroplasia, and malignant tumors, which require new blood vessels for continued growth.
antihemophilic factor
ABBR: AHF Coagulation factor VIII, a glycoprotein clotting factor essential for the formation of blood thromboplastin. A deficiency results in hemophilia A.
SEE: blood coagulation; SEE: coagulation factor
atrial natriuretic factor
A peptide secreted by the atrial tissue of the heart in response to an increase in blood pressure. It influences blood pressure, blood volume, and cardiac output. It increases the excretion of sodium and water in urine, thereby lowering blood volume and blood pressure and influencing cardiac output. Its secretion rate depends on glomerular filtration rate and inhibits sodium reabsorption in distal tubules. These actions reduce the workload of the heart.
SYN: SEE: atrial natriuretic hormone; SEE: atrial natriuretic peptide; SEE: atriopeptin
autocrine factor
A growth factor produced by the cell that stimulates the same cell to grow.
autocrine motility factor
A chemical released by cancer cells that induces motility, enabling the cells to metastasize.
B cell activating factor
B cell growth factor
SEE: Interleukin-4.
B cell stimulatory factor II
SEE: Interleukin-6.
Bucky factor
SEE: Bucky, Gustav P.
cervical factor
In infertile women, any disease of the uterine cervix that prevents conception, e.g., cervical stenosis.
Christmas factor
SEE: Christmas, Stephen
citrovorum factor
SEE: Leucovorin.
clotting factor
SEE: Coagulation factor.
coagulation factor
Any of the factors involved in blood clotting. The generally accepted terms for the factors and their Roman numeral designations are as follows:
factor I, fibrinogen; factor II, prothrombin; factor III, thromboplastin; factor IV, calcium (ions); factor V, proaccelerin; factor VII, serum prothrombin conversion accelerator; factor VIII, antihemophilic factor; factor IX, plasma thromboplastin component; factor X, Stuart-Prower factor; factor XI, plasma thromboplastin antecedent; factor XII, Hageman factor; factor XIII, fibrin-stabilizing factor; prekallikrein; and high-molecular-weight kininogen, also called Fitzgerald, Flaujeac, or Williams factor, or contact activation cofactor. Factor VI, once called accelerin, is no longer used.
SYN: SEE: clotting factor
SEE: blood coagulation
colony-stimulating factor-1
ABBR: CSF-1 A protein in human serum that promotes monocyte differentiation.
SEE: granulocyte-macrophage colony-stimulating factor
contact factor
SEE: Hageman factor.
correction factor
A number by which a measured value is multiplied to correct for systematic measurement error.
corticotropin-releasing factor
drop factor
The number of drops of an infusion that add to a volume equal to 1 milliliter.
edema factor
An enzyme made by Bacillus anthracis. It causes the cellular and tissue swelling characteristic of anthrax infection.
endothelium-derived hyperpolarizing factor
ABBR: EDHF A vasodilating substance released by the vascular endothelium.
SEE: endothelium
endothelium-derived relaxing factor
ABBR: EDRF An active vasodilator released by the vascular endothelium. It facilitates relaxation of vascular smooth muscle and inhibition of adhesion and aggregation of platelets. When the normal function of the endothelium is disrupted by mechanical trauma, hypertension, hypercholesterolemia, or atherosclerosis, less EDRF is released, and the inhibition of platelet aggregation is decreased. In addition, the damaged vessels constrict, which favors the formation of thrombi.
SEE: endothelium
eosinophil chemotactic factor
A mediator released in response to inflammation when mast cells are injured.
eosinophil colony-stimulating factor
SEE: Interleukin-5.
eosinophil differentiation factor
SEE: Interleukin-5.
epidermal growth factor
ABBR: EGF A polypeptide that stimulates growth of several different cells, including keratinocytes. A receptor for EGF is located on the surface of many cancer cells. It has been used experimentally to promote wound healing.
extrinsic factor
SEE: 1. Serum prothrombin conversion accelerator.
2. An obsolete term for vitamin B12.
SEE: pernicious anemia.
fibrin-stabilizing factor
ABBR: FSF Coagulation factor XIII, a clotting factor that is active in the intrinsic, extrinsic, and common pathways of coagulation and, when activated by thrombin, transforms monomeric fibrin to stable fibrin polymers.
SYN: SEE: plasma transglutaminase
SEE: blood coagulation; SEE: coagulation factor
fibroblast growth factor
Any of a group of polypeptides that stimulate the growth of tissues rich in fibroblasts, including blood vessels, connective tissues, and skin. Overactivity of these factors has been associated with neoplasia.
general intelligence factor
ABBR: g The hypothetical common feature identified by all intelligence (IQ) tests. The concept of general intelligence was developed by Charles Spearman, a British psychologist and statistician, who noticed that students who do well in one subject tend to do well in all school subjects and that students who do poorly in one field of study also lag behind in others. He proposed that the general ability to master academic material was due to superior general intelligence and that specific cognitive talents correlated with overall intellectual superiority. This concept, like many others in the field of psychometrics and intelligence testing, is controversial.
granulocyte colony-stimulating factor
ABBR: G-CSF A naturally occurring cytokine glycoprotein that stimulates the proliferation and functional activity of neutrophils. It is effective in treating bone marrow deficiency after cancer chemotherapy or bone marrow transplantation. The generic name is filgrastim.
SEE: colony-stimulating factor-1
granulocyte-macrophage colony-stimulating factor
ABBR: GM-CSF A naturally occurring cytokine glycoprotein that stimulates the production of neutrophils, monocytes, and macrophages. It is effective in treating bone marrow deficiency following cancer chemotherapy or bone marrow transplantation. The generic name is sargramostim; trade names are Leukine and Prokine.
SEE: colony-stimulating factor-1
growth factor
ABBR: GF A substance (generally a protein, polypeptide, or peptide) that stimulates the differentiation, division, development, and maintenance of cells and the tissues they make up. Growth factors are signaling molecules released by certain groups of cells, e.g., lymphocytes, to influence the activities of other cells. Growth factors can be divided into families, e.g., platelet-derived GFs, transforming GFs, and angiogenic GFs. They are released normally during fetal and embryonic development, wound healing, and tissue maturation. Massive releases of GFs are characteristic of some types of cancer cells. Artificial GFs, e.g., granulocyte colony-stimulating factor, are used in health care to restore depressed levels of cells to normal values, e.g., in patients who have received chemotherapy.
SYN: SEE: trophic factor
SEE: cytokine
factor H
A plasma glycoprotein that downregulates the alternative pathway of complement. The alternative pathway of complement is an antibody-independent mechanism the body uses to defend itself against pathogenic bacteria.
Hageman factor
Coagulation factor XII, a serine protease, not vitamin-K-dependent, involved in the intrinsic pathway of coagulation.
SYN: SEE: contact factor
SEE: blood coagulation; SEE: coagulation factor
hematopoietic growth factor
Any of a group of at least 17 substances involved in the production of blood cells, including several interleukins and erythropoietin.
heparin-binding epidermal growth factor
ABBR: HB-EGF A cytokine monokine involved in immune and inflammatory responses. It is produced by macrophages and stimulates production of smooth muscle cells and fibroblasts.
hepatocyte growth factor
A cytokine monokine involved in immune and inflammatory responses. It is produced by platelets, fibroblasts, macrophages, endothelial cells, and smooth muscle cells. It stimulates growth of hepatocytes and increases migration and motility of various epithelial and endothelial cells.
hepatocyte stimulatory factor
SEE: Interleukin-6.
human factor
A general term for several areas of research that include human performance, technology, design, and human-computer interaction. It focuses on human abilities, limitations, and characteristics as they relate to their environment.
hypoxia-inducible factor
A factor within aerobic cells that helps them adapt to abnormally low oxygen concentrations.
insulin sensitivity factor
ABBR: ISF The decrease in blood sugar produced by each unit of injected insulin. The ISF varies from person to person.
insulin-like growth factor
ABBR: IGF Any of a group of related peptides, synthesized by the liver as a result of human growth hormone secretion. The IGF family of polypeptides is structurally similar to insulin in that it is composed of two subunits that are short polypeptides: IGF-1 (somatomedin) and IGF-2, for example, each contain about 70 amino acids. They have a wide variety of functions, including the stimulation of cell growth and proliferation (as in the developing embryo and neonate), DNA synthesis, bone growth, and the replication of cancer cells. Drugs that block IGF have been tested for use in cancer chemotherapy.
intrinsic factor
A glycoprotein secreted by the parietal cells of the gastric mucosa. It is necessary for the absorption of ingested vitamin B12. The absence of this factor leads to vitamin B12 deficiency and pernicious anemia.
SYN: SEE: Castle intrinsic factor
keratinocyte growth factor
A growth factor that stimulates epithelial cells to proliferate.
labile factor
SEE: Proaccelerin.
lethal factor
1. A gene or an abnormality in genetic composition that causes death of a zygote or of an individual before reproductive age.
2. A protein made by Bacillus anthracis. It splits signal transduction proteins within infected cells, resulting in cellular dysfunction and death.
leukemia inhibitory factor
ABBR: LIF A cytokine that regulates the growth and differentiation of many cells throughout the body, including endothelial cells, fat cells, embryonic stem cells, germ cells, osteoblasts, and peripheral nerve cells.
leukocyte inhibitory factor
leukocyte migration inhibition factor
ABBR: LMIF A lymphokine that inhibits movement of neutrophils.
SYN: SEE: leukocyte inhibitory factor
lipotropic factor
Any of the compounds that promote the transportation and use of fats and help to prevent accumulation of fat in the liver.
lymphocyte mitogenic factor
ABBR: LMF A lymphokine that stimulates production of lymphocytes and other lymphokines.
macrophage activating factor
ABBR: MAF A lymphokine that stimulates macrophages to become more effective killers of certain microbial cells. Macrophages stimulated by MAF can kill tumor cells.
macrophage chemotactic factor
ABBR: MCF A lymphokine released by T and B cell lymphocytes in response to an antigen. It attracts macrophages to the site of the invading antigen.
macrophage colony stimulating factor
ABBR: M-CSF A hematopoietic growth factor that stimulates monocytes to form colonies.
magnification factor
ABBR: MF A quantitative expression of the degree of enlargement of an image in which the image size is divided by object size. In radiography, it is the ratio of the source-to-image-receptor distance to the source-to-object distance.
male factor
Any cause for a couple's difficulty in conceiving a child that results from diseases of the male reproductive organs, e.g., a low sperm count.
mast cell growth factor
SEE: Interleukin-3.
mast cell growth factor II
SEE: Interleukin-4.
maturation-promoting factor
ABBR: MPF A complex cellular protein that stimulates cell division in eukaryotic cells. Part of MPF is the protein cyclin, which accumulates during interphase and triggers mitosis or meiosis.
SYN: SEE: M-phase promoting factor
milk factor
A substance present in certain strains of mammary cancer-prone mice that is transferred to offspring through milk from the mammary glands. It can induce the development of mammary cancer in suckling mice exposed to the factor.
modifiable risk factor
A risk factor for a disease that can be controlled or affected by changes in behavior.
M-phase promoting factor
multi-colony stimulating factor
SEE: Interleukin-3.
natural killer cell stimulating factor
SEE: Interleukin-12.
neutrophil chemotactic factor
A lymphokine that attracts neutrophils, but not other white blood cells, and causes proteolytic damage in sepsis and trauma.
nerve growth factor
ABBR: NGF A protein necessary for the growth and maintenance of sympathetic and certain sensory neurons.
SYN: SEE: neurotrophin
neurotrophic factor
Any member of a family of growth factors that contribute to the selective survival or proliferation of nerves.
SYN: SEE: neurotrophin
osteoclast-activating factor
ABBR: OAF A lymphokine produced in certain conditions associated with resorption of bone, including periodontal disease and lymphoid malignancies such as multiple myeloma and malignant lymphoma. Interleukin-1 and other substances produced by T lymphocytes and prostaglandins are OAFs.
osteoclastogenesis inhibitory factor
ABBR: OCIF A protein produced by activated T cells that inhibits the proliferation of osteoclasts.
SYN: SEE: osteoprotegerin
ovarian factor
Any cause of female infertility that results from failure of egg production by the ovaries.
ovulatory factor
1. In women who are infertile, any disease or condition that interferes with the monthly release of an unfertilized egg from the ovaries.
2. In ovarian cancer, the carcinogenic effect of ovulation on the surface epithelium of an ovary.
plasmacytoma simulating factor
SEE: Interleukin-11.
platelet-activating factor
ABBR: PAF A phospholipid that affects the signaling between cells in important body processes such as inflammation, sepsis, and thrombosis. It is released by mast cells, basophils, and activated eosinophils.
platelet-derived growth factor
A polypeptide that stimulates collagen synthesis, smooth muscle formation, tissue repair, and the proliferation of fibroblasts and microglia.
platelet tissue factor
SEE: Thromboplastin.
pre-B cell growth factor
A polypeptide that stimulates collagen synthesis, smooth muscle formation, tissue repair, and the proliferation of fibroblasts and microglia.
predictive factor
A characteristic of a patient that indicates a greater or lesser likelihood of responding to a specific treatment regimen.
procoagulant factor
A lymphokine that can assume the role of factor VIII (antihemophilic factor) in coagulation cascade.
prognostic factor
Any feature of a disease or of a patient's presentation that suggests that he or she will be affected for better or worse by an illness.
quality factor
ABBR: Q In radiology, a scale used to account for the biological effects of different radiations. Factors include beta, electron, and gamma x-radiation (Q = 1), thermal neutrons (Q = 5), and alpha neutrons and protons (Q = 20).
R factor
resistance transfer factor
ABBR: RTF A genetic factor in bacteria that controls resistance to certain antibiotic drugs. The factor may be passed from one bacterium to another. This makes it possible for nonpathogenic bacteria to become resistant to antibiotics and to transfer that resistance to pathogens, thereby establishing a potential source for an epidemic.
SYN: SEE: R factor
SEE: plasmid
Rh factor
An antigen found on the membranes of the red blood cells. It was discovered in 1940 by Karl Landsteiner and Alexander S. Wiener, who prepared anti-Rh serum by injecting red cells from Rhesus monkeys into rabbits and other animals. They found that the red cells of 85% of Europids agglutinates in contact with anti-Rh serum. These people are called Rh-positive. The remaining 15%, whose red cells are not agglutinated by anti-Rh serum, are called Rh-negative. More than 25 blood factors are known to belong to the Rh system. Rh incompatibility between mother and fetus is the cause of hemolytic disease of the newborn.
rheumatoid factor
ABBR: RF Antibodies raised by the body against immunoglobulins. They are present in roughly 80% of patients with rheumatoid arthritis and in many patients with other rheumatological and infectious illnesses. This factor is used, with other clinical indicators, in the diagnosis and management of rheumatoid arthritis.
risk factor
An environmental, chemical, psychological, physiological, or genetic element that predisposes someone to the development of a disease. Risk factors for coronary artery disease include hypertension, high circulating blood lipids and cholesterol, obesity, cigarette smoking, diabetes mellitus, physical inactivity, microalbuminuria, chronic kidney disease, and an early family history of atherosclerosis.
SYN: SEE: risk marker
spreading factor
The hyaluronidase made by Bacillus anthracis.
SEE: hyaluronidase
stable factor
susceptibility factor
A condition that increases a person's likelihood of acquiring a disease. The propensity to develop disease is often the result of a genetic mutation in a single base DNA base pair.
stem cell factor
ABBR: SCF A cytokine glycoprotein that influences the development of sperm and egg cells, the production of melanin, and mast cell development.
Stuart-Prower factor
Coagulation factor X, a vitamin-K-dependent protease, synthesized by the liver, that, when activated to factor Xa, is the first coagulation factor in the common final pathway of blood coagulation that generates thrombin from prothrombin. The factors that lead to it are limited to the extrinsic or intrinsic coagulation pathways. The Stuart-Prower factor was formerly called “thrombokinase.”
SEE: blood coagulation; SEE: coagulation factor
T-cell growth factor
SEE: Interleukin-2.
T-cell growth factor II
SEE: Interleukin-4.
thyroid-stimulating hormone-releasing factor
ABBR: TSH-RF
SEE: thyrotropin-releasing hormone
tissue factor
ABBR: TF SEE: Thromboplastin.
transfer factor
Any of the low-molecular-weight chemicals extracted from immune cells activated to respond to specific antigens. These products can be taken from a sensitized person and given to another. The recipient will react to the same antigen originally used to sensitize the lymphocytes of the donor. The factor can be transferred by injecting the recipient with either intact lymphocytes or extracts of disrupted cells. It has been studied as adjunctive therapy to modulate the immune system in several clinical trials.
transforming growth factor
ABBR: TGF A polypeptide cytokine with multiple functions that binds to epidermal growth factor receptors. It blocks T lymphocytes from entering tumors (suppressing the immune response to cancer), promotes the growth of fibroblasts, and has numerous other physiological functions.
trophic factor
SEE: Growth factor
tubal factor
Any abnormality of the fallopian tubes that produces infertility.
tumor angiogenesis factor
ABBR: TAF A protein in animal and human cancer tissue that in experimental studies appears to be essential to growth of the cancer. This factor is thought to act by stimulating the growth of new blood capillaries that supply the tumor with nutrients and remove waste products.
tumor necrosis factor
ABBR: TNF A polypeptide protein mediator or cytokine released primarily by macrophages and T lymphocytes. It helps regulate the metabolism of fats, the immune response, and some hematopoietic functions. There are two factors: alpha (TNFα), also called cachectin, produced by macrophages; and beta (TNFβ), called lymphotoxin, produced by activated CD4+ T cells. The functions of TNF are similar to those of interleukin-1. A monoclonal antibody against TNFα, infliximab, is used to treat rheumatoid arthritis and other diseases in which TNFα causes inflammatory damage. Antagonists to tumor necrosis factor, e.g., adalimumab, etanercept, and infliximab, are used to treat diseases affected by TNF, such as rheumatoid arthritis or Crohn disease.
SEE: cytokine; SEE: interleukin-1
uterine factor
Any abnormality of the uterus that produces infertility.
V factor
vascular endothelial growth factor
ABBR: VEGF A growth factor produced by endothelial cells that promotes angiogenesis and increases microvascular permeability. Inhibitors of VEGF are used to treat a variety of cancers. Their use is associated with hypertension, which sometimes may be severe.
virulence factor
A substance released by a microorganism that allows it to evade host defenses or cause serious injury to its host. Although most virulence factors are released by bacteria for their own benefit, sometimes factors released by one microorganism foster another disease-causing organism.
windchill factor
Loss of heat from exposure of skin to wind. Heat loss is proportional to the speed of the wind. Thus, skin exposed to a wind velocity of 20 mph (32 km/hr) when the temperature is 0°F (−17.8°C) is cooled at the same rate as in still air at −46°F (−43.3°C). Similarly, when the temperature is 20°F (−6.7°C) and the wind is 10, 20, or 35 mph (16.1, 32.2, or 56.3 km/hr), the equivalent skin temperature is −4°, −18°, or −28°F (−20°, −27.8°, or −33.3°C), respectively.
The windchill factor is calculated for dry skin; skin that is wet from any cause and exposed to wind loses heat at a much higher rate. Wind blowing over wet skin can cause frostbite, even on a comfortably warm day as judged by the thermometer.
X factor
A growth factor, identified as hemin, that is needed to grow Haemophilus influenzae in culture.
SEE: hemin
